Molecular biomarkers for the early detection of ovarian cancer
R Zhang, MKY Siu, HYS Ngan, KKL Chan - International Journal of …, 2022 - mdpi.com
Ovarian cancer is the deadliest gynecological cancer, leading to over 152,000 deaths each
year. A late diagnosis is the primary factor causing a poor prognosis of ovarian cancer and …
year. A late diagnosis is the primary factor causing a poor prognosis of ovarian cancer and …
[HTML][HTML] Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis
EMJ Meys, J Kaijser, R Kruitwagen… - European Journal of …, 2016 - Elsevier
Introduction Many national guidelines concerning the management of ovarian cancer
currently advocate the risk of malignancy index (RMI) to characterise ovarian pathology …
currently advocate the risk of malignancy index (RMI) to characterise ovarian pathology …
Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist
KGM Moons, JAH de Groot, W Bouwmeester… - PLoS …, 2014 - journals.plos.org
Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling
Studies: The CHARMS Checklist | PLOS Medicine Skip to main content Advertisement …
Studies: The CHARMS Checklist | PLOS Medicine Skip to main content Advertisement …
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group
Objectives To prospectively assess the diagnostic performance of simple ultrasound rules to
predict benignity/malignancy in an adnexal mass and to test the performance of the risk of …
predict benignity/malignancy in an adnexal mass and to test the performance of the risk of …
Management of asymptomatic ovarian and other adnexal cysts imaged at US: Society of Radiologists in Ultrasound Consensus Conference Statement
D Levine, DL Brown, RF Andreotti, B Benacerraf… - Radiology, 2010 - pubs.rsna.org
The Society of Radiologists in Ultrasound convened a panel of specialists from gynecology,
radiology, and pathology to arrive at a consensus regarding the management of ovarian and …
radiology, and pathology to arrive at a consensus regarding the management of ovarian and …
Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis
J Kaijser, A Sayasneh, K Van Hoorde… - Human reproduction …, 2014 - academic.oup.com
BACKGROUND Characterizing ovarian pathology is fundamental to optimizing
management in both pre-and post-menopausal women. Inappropriate referral to oncology …
management in both pre-and post-menopausal women. Inappropriate referral to oncology …
Multi-biomarker panel signature as the key to diagnosis of ovarian cancer
T Muinao, HPD Boruah, M Pal - Heliyon, 2019 - cell.com
Early detection of ovarian cancer has been a challenge to manage the high mortality rate
caused by this deadly disease. The trends in mortality have been reduced by the scientific …
caused by this deadly disease. The trends in mortality have been reduced by the scientific …
Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies
J Kaijser, T Bourne, L Valentin… - … in obstetrics & …, 2013 - Wiley Online Library
In order to ensure that ovarian cancer patients access appropriate treatment to improve the
outcome of this disease, accurate characterization before any surgery on ovarian pathology …
outcome of this disease, accurate characterization before any surgery on ovarian pathology …
The meaning of significant mean group differences for biomarker discovery
Over the past decade, biomarker discovery has become a key goal in psychiatry to aid in the
more reliable diagnosis and prognosis of heterogeneous psychiatric conditions and the …
more reliable diagnosis and prognosis of heterogeneous psychiatric conditions and the …
Lymph node metastasis in stages I and II ovarian cancer: a review
M Kleppe, T Wang, T Van Gorp, BFM Slangen… - Gynecologic …, 2011 - Elsevier
OBJECTIVES: The purpose of this review is to determine the incidence of lymph node
metastases in clinical stages I and II ovarian cancer. METHODS: Relevant articles were …
metastases in clinical stages I and II ovarian cancer. METHODS: Relevant articles were …